Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

Motesanib inhibits Kit mutations associated with gastrointestinal stromal tumors

<p>Abstract</p> <p>Background</p> <p>Activating mutations in Kit receptor tyrosine kinase or the related platelet-derived growth factor receptor (PDGFR) play an important role in the pathogenesis of gastrointestinal stromal tumors (GIST).</p> <p>Methods</...

Full description

Bibliographic Details
Main Authors: Tasker Andrew S, Manoukian Raffi, Juan Todd, Baron Will, Bush Tammy L, Baher Angelo, Renshaw-Gegg Lisa, Caenepeel Sean, Polverino Anthony, Hughes Paul E
Format: Article
Language:English
Published: BMC 2010-07-01
Series:Journal of Experimental & Clinical Cancer Research
Online Access:http://www.jeccr.com/content/29/1/96

Internet

http://www.jeccr.com/content/29/1/96

Similar Items